Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

A judicial review may force the Health Secretary to prohibit cross-sex drugs for children, led by Keira Bell, who regretted ...

For the current study, the investigators assessed the link between WNT9B gene mutations and risk of prostate cancer across 4 independent biobanks. Associations were uncovered using a case-control ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground ... paid for by those who can afford it. Prostate cancer is now the most common cancer in the UK, according ...

There are self-care strategies that may aid in helping to prevent prostate cancer, the second most common cause of cancer-related death in men. Located below the bladder, the prostate is the gland ...

Prioritising gut health, Shand argues, is a key way to regulate hormones naturally and avoid potential health risks like osteoporosis or breast cancer, particularly in post-menopausal women.

prostate, ovarian, and colorectal cancers. Both of these innovative anticancer therapies, developed through cutting-edge oncology research, are protected by international patents and set to ...